BG60207B2 - Process for preparing n-substituted 3-acyl-2-oxindole-1-carboxamides - Google Patents

Process for preparing n-substituted 3-acyl-2-oxindole-1-carboxamides

Info

Publication number
BG60207B2
BG60207B2 BG096583A BG9658392A BG60207B2 BG 60207 B2 BG60207 B2 BG 60207B2 BG 096583 A BG096583 A BG 096583A BG 9658392 A BG9658392 A BG 9658392A BG 60207 B2 BG60207 B2 BG 60207B2
Authority
BG
Bulgaria
Prior art keywords
oxindole
carboxamides
acyl
substituted
preparing
Prior art date
Application number
BG096583A
Other languages
Bulgarian (bg)
Inventor
Saul Kadin
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG60207B2 publication Critical patent/BG60207B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The obtained compounds are used as analgesics and anti-inflammatory agent. According to the method, a compound of the formula wherein X and Y mean hydrogen, and R1 is methyl, trifluoromethyl, phenoxymethyl, phenylalkyl, having 1 to 2 hydrogen atoms in the alkyl group, pyridile, furyl, furylmethyl, thienyl or thienylmethyl reacts with an isocyanate in the presence of inert solvent at a temperature in the range from 50 to 150oC.
BG096583A 1984-05-04 1992-07-08 Process for preparing n-substituted 3-acyl-2-oxindole-1-carboxamides BG60207B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (1)

Publication Number Publication Date
BG60207B2 true BG60207B2 (en) 1993-12-30

Family

ID=24431933

Family Applications (2)

Application Number Title Priority Date Filing Date
BG070071A BG60208B2 (en) 1984-05-04 1985-05-03 Process for preparingn-substituted 3-acyl-2-oxindole-1-carboxamides
BG096583A BG60207B2 (en) 1984-05-04 1992-07-08 Process for preparing n-substituted 3-acyl-2-oxindole-1-carboxamides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG070071A BG60208B2 (en) 1984-05-04 1985-05-03 Process for preparingn-substituted 3-acyl-2-oxindole-1-carboxamides

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL147508B1 (en)
PT (1) PT80375B (en)
RO (2) RO94455B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
JPH0335315B2 (en) 1991-05-27
PL147508B1 (en) 1989-06-30
AR241159A1 (en) 1991-12-30
PT80375B (en) 1987-09-30
ES542813A0 (en) 1986-07-16
MA20424A1 (en) 1985-12-31
KR850008154A (en) 1985-12-13
PT80375A (en) 1985-05-01
ES551275A0 (en) 1987-07-16
ZA853324B (en) 1986-12-30
CS320285A2 (en) 1987-03-12
JPS60243068A (en) 1985-12-03
NO163132B (en) 1990-01-02
ES8609248A1 (en) 1986-07-16
HUT37754A (en) 1986-02-28
NO163132C (en) 1990-04-11
IN161509B (en) 1987-12-19
RO91141B (en) 1987-07-03
FI80016C (en) 1990-04-10
AR241159A2 (en) 1991-12-30
RO91141A (en) 1987-06-30
BG60208B2 (en) 1993-12-30
RU2017729C1 (en) 1994-08-15
DD232916A5 (en) 1986-02-12
SU1468413A3 (en) 1989-03-23
ZW7885A1 (en) 1985-07-24
HU196057B (en) 1988-09-28
FI80016B (en) 1989-12-29
PL253203A1 (en) 1986-06-17
IE851103L (en) 1985-11-04
FI851756A0 (en) 1985-05-03
NO851774L (en) 1985-11-05
MW1685A1 (en) 1986-09-10
ES8707182A1 (en) 1987-07-16
PL257892A1 (en) 1986-10-07
RO94455B (en) 1988-07-01
EG17193A (en) 1990-08-30
YU73085A (en) 1988-04-30
RO94455A (en) 1988-06-30
MX5839A (en) 1993-11-01
YU44998B (en) 1991-06-30
KR870000497B1 (en) 1987-03-12
PL145416B1 (en) 1988-09-30
FI851756L (en) 1985-11-05
CS252828B2 (en) 1987-10-15
OA08098A (en) 1987-03-31

Similar Documents

Publication Publication Date Title
EP0176927A3 (en) Diazepine-containing pharmaceutical compositions having a platelet activating factor (paf)-antagonist action
ES8103088A1 (en) Spiro-(dihydrobenzofuranpiperidines and -pyrrolidines) and derivatives thereof, methods for their preparation and medicines containing them.
NO179868C (en) Analogous Process for Preparing Therapeutically Active Condensed Heterocyclic Compounds
KR830007597A (en) Method for preparing 3-aryl-5-isothiazole derivative
ES8406419A1 (en) Arene and heteroarene carboxamide derivatives, process for their preparation and medicaments containing them.
IE41528L (en) Furfuryl-benzomorphane derivatives.
GB1464583A (en) Preparation of quinazoline derivatives
ES382550A1 (en) 2-(aminoalkyl-amino)-4-amino thieno(3,2-d)pyrimidines
ES8609225A1 (en) Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same.
BG60207B2 (en) Process for preparing n-substituted 3-acyl-2-oxindole-1-carboxamides
KR870002069A (en) Method for preparing 2- (3,5-dialkyl-4-hydroxyphenyl) indole derivative
ES8704486A1 (en) Rhodanine derivatives and a process for preparing same.
ES8701174A1 (en) Thiadiazine compound, process for its preparation and pharmaceutical compositions containing it.
HUT49581A (en) Process for producing imidazole derivatives and pharmaceutical compositions comprising same
IE810728L (en) Pyrazole derivatives.
RS49832B (en) Method for preparing alkyloxy furanone derivatives, compounds obtained by sajd method and use of sajd compounds
KR840001154A (en) Method for preparing 1,2-dithiol-3-ylidene ammonium derivative
DE68907953D1 (en) METHOD FOR PRODUCING 2-BETA SUBSTITUTED METHYL PENICILLINE DERIVATIVES.
JPS57183768A (en) 4-methyl-5-(o-carboxyphenyl)carbamoylthiazole derivative and its preparation
IE802112L (en) Pyridine derivatives.
IE831075L (en) Thiophene derivatives
ES465346A1 (en) 2h-imidazole-2-thione derivatives
GB1471851A (en) Diaminomaleonitrile derivatives and processes for preparing the same
ES8802300A1 (en) 3-aryloxyazetidinecarboxamide-containing composition as muscle relaxant and antianxiety
ES8302668A1 (en) A method of production of a substituted 3,5-dt-t-butil-4-hidroxifenil-heterociclico compound. (Machine-translation by Google Translate, not legally binding)